Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $314 Million
  • Q3 2024

Johnson & Johnson has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $314 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $110M, Legend Biotech Corp with a value of $39.7M, Cv Rx, Inc. with a value of $36.2M, Nanobiotix S.A. with a value of $32.3M, and Procept Bio Robotics Corp with a value of $28.7M.

Examining the 13F form we can see an increase of $24.2M in the current position value, from $290M to 314M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $314 Million
Healthcare: $314 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $314 Million
  • Prior Value $290 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email